R56.8 G40.9
Conditions
Interventions
Group 1: After a first epileptic seizure participants will be longterm-followed up and interviewed and examined on a regular basis (6 months resp. 12 months intervals). Interviews comprise epileptolog
Sponsors
Charité Universitätsmedizin Berlin; Klinik für Neurologie; Epilepsie-Zentrum Berlin -Brandenburg
Eligibility
Sex/Gender
All
Age
14 Years to No maximum
Inclusion criteria
Inclusion criteria: People with a first diagnosed epileptic seizure within the last three months (excluding former febrile seizures) who agree to participate in the study according to written informed consent, who are at least 14 yo and whose Primary residence is within Berlin/Brandenburg
Exclusion criteria
Exclusion criteria: 1.) psychogenic non-epileptic seizures (additional or exclusive) 2.) cognitive impairment as well as severe organic disease, which compromise participation in the study 3.) relevant language barrier
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occurrence of recurrent epileptic seizures, development of pharmacoresistence in case of antiseizure-medication, death/mortality riskwithin 5 yrs after the first epileptic seizure. Identification of prognostic influencing variables. | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence of recurrent epileptic seizures, development of pharmacoresistence in case of antiseizure-medication, death/mortality risk in longterm-follow-up (>10 yrs) after the first epileptic seizure. Identification of prognostic influencing variables. | — |
Countries
Germany
Contacts
Public ContactDorothea Kutscha
Charité - Universitätsmedizin Berlin; Klinik und Hochschulambulanz für Neurologie; Klinische und experimentelle Epileptologie
Outcome results
None listed